29/12/2025 - General information
A clinical trial led by a team from the Hospital del Mar Research Institute, in collaboration with Hospital de la Santa Creu i Sant Pau, has received nearly €1.3 million in funding from Spain's Carlos III Health Institute (ISCIII), under the 2025 call of the Strategic Action in Health-Strategic Lines of Health Research. It is one of the 14 clinical trials selected. The trial is led by Dr. Ana Aldea, coordinator of the HMRIB Clinical Research Unit and Head of the Clinical Pharmacology Section at Hospital del Mar, and Dr. Rafael de la Torre, coordinator of the Integrated Pharmacology and Systems Neuroscience Research Group at the Hospital del Mar Research Institute.
24/12/2025 - General information
23/12/2025 - General information
The Joan Oró grants aim to fund the recruitment of predoctoral researchers in training who pursue their PhD studies within the Catalan university system. These grants help promote the training and research activities of the recruited researchers and increase their qualifications and professional development during the early stages of their research careers, thereby strengthening the generation of cutting-edge knowledge and its transfer.
18/12/2025 - General information
The study published last April in PNAS by the team led by Dr Pilar Navarro, coordinator of the Cancer Molecular Targets Research Group at the Hospital del Mar Research Institute and the IIBB-CSIC-IDIBAPS, has been selected by Nature as one of the ‘Six highlights from pancreatic cancer research’ of 2025.
24/11/2025 - General information
The new edition of the Highly Cited Researchers ranking, produced by Clarivate, has selected 6,868 researchers worldwide who have demonstrated significant influence in their research fields over the past eleven years. Two researchers from the Hospital del Mar Research Institute, Dr Jordi Alonso and Dr Joaquim Bellmunt, are once again included in the ranking. The researchers featured in the ranking work across around sixty countries. The United States leads the list, followed by China and the United Kingdom. Only around ninety of the selected researchers work in institutions in Spain.
18/11/2025 - General information
Solidarity, through La Marató de 3Cat, continues to drive research. The 10 million euros raised in the latest edition, dedicated to respiratory diseases, will be used to fund 36 research projects from sixty research groups. Among them are two projects led by researchers from the Hospital del Mar Research Institute and Hospital del Mar. One of the projects, led by Dr. Joan Ramon Masclans, head of the Intensive Care Medicine Service at Hospital del Mar and coordinator of the Critical Illness Research Group at the HMRIB, will focus on predicting treatment response in patients with acute hypoxemic respiratory failure treated with high-flow nasal cannula, using omics and clinical data. To do so, they will receive nearly 300,000 euros. The project also involves the Institute for Bioengineering of Catalonia (IBEC).
17/11/2025 - General information
Dr José Yélamos López has received the Carmen Delgado/Miguel Pérez Mateo Grant in the basic research category. The award ceremony for the grant, worth 100,000 euros, took place on 5 November. These grants are awarded by the Pancreatic Cancer Association, in collaboration with the Spanish Association of Pancreatology and the Spanish Association of Gastroenterology, with the aim of promoting basic and clinical research in pancreatic cancer. They are made possible thanks to the public's participation in the Carrera de las Ciudades contra el Cáncer de Páncreas (Cities Race Against Pancreatic Cancer), which in 2025 reached its tenth edition.
Més informació "Carmen Delgado/Miguel Pérez Mateo Grant for Dr José Yélamos López"
11/11/2025 - General information
Dr. Anna Bigas, coordinator of the Stem Cells and Cancer Research Group at the Hospital del Mar Research Institute and the Josep Carreras Leukaemia Research Institute, has just joined the journal Development as an Associate Editor. The journal is published by The Company of Biologists, a non-profit organization led by leading scientists in the field. This is one of the reference publications in its area. Dr. Bigas will be responsible for evaluating and deciding on the publication of studies related to the development of hematopoietic stem cells and how their deregulation contributes to the onset of blood diseases.
Més informació "Dr. Anna Bigas begins a new chapter as Associate Editor of the journal Development"
04/11/2025 - General information
The Pharmacokinetics and Pharmacodynamics (PK/PD) Research Team at Hospital del Mar has received a competitive international grant awarded by the pharmaceutical company Pfizer, as part of the "Independent Research Grant Program - Pharmacokinetics-pharmacodynamics (PK/PD) of Aztreonam-Avibactam (ATM-AVI) in Special Populations." The selected project, chosen among proposals from several European centers, aims to optimize the use of the new antibiotic aztreonam-avibactam in patients with renal impairment - a population particularly vulnerable to severe infections caused by multidrug-resistant bacteria. The project is led by Dr. Mila Montero and Dr. Sònia Luque.
Més informació "Pfizer International Grant for a Project at Hospital del Mar on Antibiotic Therapy"
22/10/2025 - General information
The Hemodynamics Unit of the Cardiology Department at Hospital del Mar took part in a study published in the New England Journal of Medicine. The study demonstrates that one month after undergoing treatment for a myocardial infarction, patients can safely continue therapy with a single antiplatelet drug without added risk.
Servei de Comunicació:
Marta Calsina(ELIMINAR)
Tel:
(+34) 93 316 06 80
Doctor Aiguader, 88
08226 Barcelona
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact
